Pre-conception care: guidelines
Below find guidance from: the Faculty of Sexual and Reproductive Healthcare (FSRH) Clinical Effectiveness Unit (CEU) and the National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summaries (CKS) service on the topic of pre-conception care.
Use of valproate: guidelines from the Royal College of of Paedicatrics and Child Health (RCPCH), NICE and, separately, the Medicines and Heathcare products Regulatory Agency (MHpRA) on the use of valproate in children, young people and adults.
FSRH
- CEU Statement on Pre-conception Care (Aug 2016)FREE
RCPCH
- Guidance Document on Valproate Use in Women and Girls of Childbearing Years - and Boys (Jan 2024 update)FREE
MHpRA
- National Patient Safety Alert: Valproate: organisations to prepare for new regulatory measures for oversight of prescribing to new patients and existing female patients (Nov 23)
- Valproate: Review of safety data and expert advice on management of risks (Nov 23) and press releaseFREE
NICE / CKS Guidance
- Spotlight on Valproate Prescribing (2024 update)FREE
- Pre-conception: Advice and management (revised Nov 2022)FREE
Last modified: Thursday, 27 June 2024, 4:21 PM